NSDL shares have surged 62.5% since its IPO, exceeding unlisted market peaks and delivering substantial gains for pre-IPO investors. The IPO, subscribed 41.02 times, reflects strong investor confidence in NSDL’s market leadership and steady financial performance. Analysts suggest a hold for allotment recipients and advise caution for new entrants amid market volatility.
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve
Laurus Labs’ stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing